The intersection of artificial intelligence (AI), digital therapeutics, and advanced communication frameworks offers transformative opportunities for addressing mental health disorders, neurodegenerative diseases, and communication challenges in modern networks. This Patent Highlight examines three pivotal patents that introduce deuterated empathogens for safer psychiatric treatments, AI-powered digital platforms for cognitive and immune function enhancement, and robust frameworks for AI/ML performance monitoring in wireless systems. Together, these innovations represent a paradigm shift in therapeutic and technological approaches, emphasizing the synergy of molecular and digital advancements in tackling global health and communication challenges.